N@N

For those with CTE, family history of mental illness tied to aggression in middle age

The article from ScienceDaily discusses a study published in the journal *Nature Communications* that explores the potential of using a common cold virus, specifically a genetically modified adenovirus, to treat glioblastoma, an aggressive form of brain cancer. Researchers from the University of Alberta found that this virus, when injected directly into the tumor, not only targets and kills cancer cells but also stimulates an immune response that could help prevent cancer recurrence. The virus was modified to enhance its cancer-killing properties while reducing its ability to cause disease in healthy cells. Initial results from a small clinical trial showed promising outcomes, with some patients experiencing significant tumor reduction and prolonged survival. The study suggests that this virotherapy could be a new avenue for treating glioblastoma, potentially offering a less invasive and more targeted approach compared to traditional treatments like chemotherapy and radiation.

Read the Full Science Daily Article at [ https://www.sciencedaily.com/releases/2024/11/241127165716.htm ]